Logo image of CRESY

CRESUD S.A.-SPONS ADR (CRESY) Stock Fundamental Analysis

NASDAQ:CRESY - Nasdaq - US2264061068 - ADR - Currency: USD

12.27  +0.3 (+2.51%)

Fundamental Rating

3

Overall CRESY gets a fundamental rating of 3 out of 10. We evaluated CRESY against 89 industry peers in the Food Products industry. CRESY has a medium profitability rating, but doesn't score so well on its financial health evaluation. CRESY is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

Of the past 5 years CRESY 4 years were profitable.
CRESY had a positive operating cash flow in 4 of the past 5 years.
CRESY Yearly Net Income VS EBIT VS OCF VS FCFCRESY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200B -400B

1.2 Ratios

CRESY has a Return On Assets (2.01%) which is comparable to the rest of the industry.
The Return On Equity of CRESY (10.99%) is better than 73.03% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.85%, CRESY is in line with its industry, outperforming 50.56% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CRESY is significantly below the industry average of 7.57%.
The 3 year average ROIC (2.55%) for CRESY is below the current ROIC(2.85%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.01%
ROE 10.99%
ROIC 2.85%
ROA(3y)4.46%
ROA(5y)1.27%
ROE(3y)25.84%
ROE(5y)3.92%
ROIC(3y)2.55%
ROIC(5y)1.98%
CRESY Yearly ROA, ROE, ROICCRESY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

Looking at the Profit Margin, with a value of 10.43%, CRESY belongs to the top of the industry, outperforming 85.39% of the companies in the same industry.
CRESY's Operating Margin of 14.92% is amongst the best of the industry. CRESY outperforms 86.52% of its industry peers.
In the last couple of years the Operating Margin of CRESY has remained more or less at the same level.
CRESY has a better Gross Margin (34.69%) than 77.53% of its industry peers.
In the last couple of years the Gross Margin of CRESY has declined.
Industry RankSector Rank
OM 14.92%
PM (TTM) 10.43%
GM 34.69%
OM growth 3Y103.59%
OM growth 5Y-0.99%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y28.68%
GM growth 5Y-1.65%
CRESY Yearly Profit, Operating, Gross MarginsCRESY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60 -80

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, CRESY has less shares outstanding
Compared to 5 years ago, CRESY has less shares outstanding
The debt/assets ratio for CRESY has been reduced compared to a year ago.
CRESY Yearly Shares OutstandingCRESY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CRESY Yearly Total Debt VS Total AssetsCRESY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1T 2T 3T

2.2 Solvency

CRESY has a Debt/Equity ratio of 1.06. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.06, CRESY is doing worse than 75.28% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
CRESY Yearly LT Debt VS Equity VS FCFCRESY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200B -200B 400B -400B 600B

2.3 Liquidity

A Current Ratio of 1.25 indicates that CRESY should not have too much problems paying its short term obligations.
CRESY's Current ratio of 1.25 is on the low side compared to the rest of the industry. CRESY is outperformed by 67.42% of its industry peers.
CRESY has a Quick Ratio of 1.25. This is a bad value and indicates that CRESY is not financially healthy enough and could expect problems in meeting its short term obligations.
CRESY has a Quick ratio (0.95) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 0.95
CRESY Yearly Current Assets VS Current LiabilitesCRESY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

More info and screens

3

3. Growth

3.1 Past

CRESY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -28.19%.
The Revenue has grown by 40.49% in the past year. This is a very strong growth!
CRESY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 71.80% yearly.
EPS 1Y (TTM)-28.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%243%
Revenue 1Y (TTM)40.49%
Revenue growth 3Y68.04%
Revenue growth 5Y71.8%
Sales Q2Q%42.13%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CRESY Yearly Revenue VS EstimatesCRESY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CRESY Price Earnings VS Forward Price EarningsCRESY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CRESY Per share dataCRESY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CRESY!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CRESUD S.A.-SPONS ADR

NASDAQ:CRESY (6/2/2025, 2:32:44 PM)

12.27

+0.3 (+2.51%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)05-09 2025-05-09
Earnings (Next)09-03 2025-09-03
Inst Owners14.26%
Inst Owner Change15.5%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap733.82M
Analysts86.67
Price TargetN/A
Short Float %2.18%
Short Ratio3.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP66.34%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpSN/A
BVpSN/A
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.01%
ROE 10.99%
ROCE 3.61%
ROIC 2.85%
ROICexc 3.31%
ROICexgc 3.34%
OM 14.92%
PM (TTM) 10.43%
GM 34.69%
FCFM N/A
ROA(3y)4.46%
ROA(5y)1.27%
ROE(3y)25.84%
ROE(5y)3.92%
ROIC(3y)2.55%
ROIC(5y)1.98%
ROICexc(3y)2.84%
ROICexc(5y)2.27%
ROICexgc(3y)2.9%
ROICexgc(5y)2.34%
ROCE(3y)3.23%
ROCE(5y)2.51%
ROICexcg growth 3Y84.33%
ROICexcg growth 5Y19.28%
ROICexc growth 3Y83.34%
ROICexc growth 5Y20.03%
OM growth 3Y103.59%
OM growth 5Y-0.99%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y28.68%
GM growth 5Y-1.65%
F-Score3
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF N/A
Debt/EBITDA 6.08
Cap/Depr 382.52%
Cap/Sales 6.51%
Interest Coverage 1.2
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.25
Quick Ratio 0.95
Altman-Z N/A
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)595.85%
Cap/Depr(5y)423.1%
Cap/Sales(3y)8.46%
Cap/Sales(5y)6.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%243%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)40.49%
Revenue growth 3Y68.04%
Revenue growth 5Y71.8%
Sales Q2Q%42.13%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-19.75%
EBIT growth 3Y242.1%
EBIT growth 5Y70.1%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1613.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-133.39%
OCF growth 3YN/A
OCF growth 5Y5.31%